Literature DB >> 6205244

Testicular function following combination chemotherapy with cis-platin, vinblastine, and bleomycin.

D H Johnson, J D Hainsworth, R B Linde, F A Greco.   

Abstract

Recovery of the pituitary-gonadal axis following treatment with vinblastine, bleomycin, cis-platin +/- doxorubicin (VBP +/- A) is assessed retrospectively in 18 men with germinal neoplasms. One patient also received VP-16-213. In the first year after completing treatment all men demonstrated elevated follicle stimulating hormone (FSH) and luteinizing hormone (LH) values with concomitant azoospermia. Of the 11 men evaluated at least 24 months from completion of therapy, seven (64%) had recovery of both FSH and LH to normal or near normal levels. Spermatogenesis was present in five of six (83%) men providing semen samples and who were at least 2 years from stopping VBP. Five of seven (71%) men who were within 24 months of therapy were azoospermic. Regardless of the time of evaluation, most men (94%) had normal serum testosterone. Patients receiving maintenance vinblastine had more prolonged elevation of serum gonadotropins. We conclude that some men have evidence of recovery of fertility beginning two years after VBP +/- A. In addition to germinal epithelium destruction, transient Leydig cell dysfunction occurs but is not accompanied by clinical findings of hypogonadism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205244     DOI: 10.1002/mpo.2950120403

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  4 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Long-term toxicity of chemotherapy for testicular cancer--the cost of cure.

Authors:  N S Stuart; C M Woodroffe; R Grundy; M H Cullen
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

3.  Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.

Authors:  Paweł J Wiechno; Maria Kowalska; Jakub Kucharz; Małgorzata Sadowska; Wojciech Michalski; Grażyna Poniatowska; Joanna Jońska-Gmyrek; Joanna Rzymkowska; Karol Nietupski; Tomasz Demkow
Journal:  Med Oncol       Date:  2017-04-07       Impact factor: 3.064

Review 4.  Clinical significance of androgen secretion disorders in men with a malignancy.

Authors:  Pawel J Wiechno; Grazyna M Poniatowska; Wojciech Michalski; Jakub Kucharz; Malgorzata Sadowska; Joanna Jonska-Gmyrek; Karol Nietupski; Joanna Rzymowska; Tomasz Demkow
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.